Clinical Trial Update: Bromocriptine in the Treatment of Peripartum Cardiomyopathy [Phase 3]

View source ↗

Summary

Phase 3 trial of bromocriptine for peripartum cardiomyopathy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripartum Cardiomyopathy

Drugs mentioned

• Bromocriptine (bromocriptine)

Snippet

Sponsor: Montreal Heart Institute | Conditions: Peripartum Cardiomyopathy | Phase 3 | Status: WITHDRAWN